Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RADIANCE Continued Access Protocol (RADIANCE CAP): A Study of the ReCor Medical Paradise System in Clinical Hypertension

NCT05017935 is registered in ClinicalTrials.gov with ReCor Medical, Inc. as lead sponsor.

NCT NCT05017935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05017935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RADIANCE Continued Access Protocol (RADIANCE CAP): A Study of the ReCor Medical Paradise System in Clinical Hypertension
Lead sponsor
ReCor Medical, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 4, 2022
Completion date
December 31, 2028
Enrollment
300 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, hypertension, hypertension, resistant to conventional therapy, vascular diseases